首页> 外文期刊>Analytical chemistry >Optimization and Evaluation of Metabolite Extraction Protocols for Untargeted Metabolic Profiling of Liver Samples by UPLC-MS
【24h】

Optimization and Evaluation of Metabolite Extraction Protocols for Untargeted Metabolic Profiling of Liver Samples by UPLC-MS

机译:UPLC-MS对肝样品进行非目标代谢谱分析的代谢物提取方案的优化和评估

获取原文
获取原文并翻译 | 示例
       

摘要

A series of six protocols were evaluated for UPLC-MS based untargeted metabolic profiling of liver extracts in terms of reproducibility and number of metabolite features obtained. These protocols, designed to extract both polar and nonpolar metabolites, were based on (i) a two stage extraction approach or (ii) a simultaneous extraction in a biphasic mixture, employing different volumes and combinations of extraction and resuspension solvents. A multivariate statistical strategy was developed to allow comparison of the multidimensional variation between the methods. The optimal protocol for profiling both polar and nonpolar metabolites was found to be an aqueous extraction with methanol/water followed by an organic extraction with dichloromethane/methanol, with resuspension of the dried extracts in methanol/water before UPLC-MS analysis. This protocol resulted in a median CV of feature intensities among experimental replicates of <20percent for aqueous extracts and <30percent for organic extracts. These data demonstrate the robustness of the proposed protocol for extracting metabolites from liver samples and make it well suited for untargeted liver profiling in studies exploring xenobiotic hepatotoxicity and clinical investigations of liver disease. The generic nature of this protocol facilitates its application to other tissues, for example, brain or lung, enhancing its utility in clinical and toxicological studies.
机译:就可重复性和获得的代谢物特征数量而言,对六种方案进行了一系列评估,以评估基于UPLC-MS的肝提取物的非靶向代谢谱。这些协议旨在提取极性和非极性代谢物,是基于(i)两阶段提取方法或(ii)在两相混合物中同时提取,采用不同体积以及提取和重悬浮溶剂的组合。开发了一种多元统计策略,可以比较这些方法之间的多维变异。发现对极性和非极性代谢物进行分析的最佳方法是用甲醇/水进行水相萃取,然后用二氯甲烷/甲醇进行有机萃取,然后将干燥的萃取液重悬于甲醇/水中,然后进行UPLC-MS分析。该协议导致实验重复的特征强度中值CV在水性提取液中小于20%,对于有机提取物小于30%。这些数据证明了所提出的从肝脏样品中提取代谢物的方案的鲁棒性,使其非常适合在探索异源性肝毒性和肝病临床研究的研究中用于非靶向肝分析。该协议的通用性质有助于将其应用于其他组织,例如脑或肺,从而增强其在临床和毒理学研究中的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号